Hypnotics, sleep, and mortality in elderly people

Area of Science:

• Gerontology
• Epidemiology
• Pharmacology

Background:

• Previous studies suggested a link between hypnotic drug use and increased mortality in the elderly.
• The specific mechanisms and types of sleep medication involved require further investigation.

Purpose of the Study:

• To re-evaluate the association between mortality, hypnotic drug use, subjective insomnia, and sleep duration in older adults.
• To differentiate the mortality risks associated with prescription hypnotics versus other sleep-related medications.

Main Methods:

• A prospective cohort study involving 1042 community-dwelling individuals aged over 65.
• Data collected from the Nottingham Longitudinal Study of Activity and Ageing, tracking 5-year mortality.
• Analysis included logistic regression to control for confounding factors such as gender, health risks, and sleep duration.

Main Results:

• A significantly higher mortality rate was observed among individuals using any form of sleep medication compared to non-users.
• Excess mortality was specifically linked to users of non-sedative "other" sleep medications, not prescription hypnotics.
• No significant associations were found between mortality and subjective insomnia or reported sleep duration.

Conclusions:

• The excess mortality associated with sleep medication use in the elderly appears to stem from self-medication with various products, acting as a marker for high morbidity.
• The study found no evidence that prescription hypnotics or sleep duration are primary drivers of this observed mortality.
• Findings suggest limited epidemiological support for a widespread interaction between benzodiazepine hypnotic use and sleep-disordered breathing in old age.